(21 days)
The V40 "/C-Taper Adapter Sleeve is intended to allow either a Howmedica Osteonics C-Taper Alumina Head or a Howmedica Osteonics C-Taper Biolox® Delta Ceramic Femoral Head to mate with a Howmedica Osteonics femoral stem with a V40" taper. The V40" /C-Taper Adapter Sleeve is a single-use device.
Indications for Use:
For Use as a Total Hip Replacement:
- Painful disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid . arthritis, post-traumatic arthritis or late stage vascular necrosis.
- Revision of previous cup arthroplasty or other procedures. .
- Clinical management problems where arthrodesis or alternative reconstructive techniques are . less likely to achieve satisfactory results.
For Use as a Bipolar Hip Replacement
- Femoral head/neck fractures or non-unions. .
- . Aseptic necrosis of the femoral head.
- Osteo- rheumatoid, and post traumatic arthritis of the hip with minimal acetabular . involvement or distortion.
Other Considerations:
- Pathological considerations or age considerations which indicate a more conservative . acetabular procedure and an avoidance of the use of bone cement in the acetabulum.
- Salvage of failed total hip arthroplasty. .
The subject V-40" /C-Taper Adapter Sleeve is a tapered sleeve component with a female V-40" taper to provide locking with a Howmedica Osteonics femoral stem with a V-40 * taper. In addition, the sleeve has a tapered male exterior surface that provides locking with Howmedica Osteonics C-Taper Alumina Ceramic Heads.
The provided document is a 510(k) Premarket Notification for a medical device, specifically a "Line Extension to the V-40™/C-Taper Adaptor Sleeve." This type of submission is for demonstrating substantial equivalence to a legally marketed predicate device, not for proving a device meets specific acceptance criteria through a study in the way a clinical trial would.
Therefore, the document does not contain the information requested for acceptance criteria and a study that proves the device meets those criteria, as it would for a new AI/diagnostic device.
Here's why and what the document does address:
- Type of Device: The device is a mechanical component for hip replacement surgery (an adapter sleeve for femoral heads). It's not a diagnostic AI or imaging device that would typically have performance metrics like sensitivity, specificity, or reader improvement studies.
- Regulatory Pathway: A 510(k) submission primarily focuses on demonstrating "substantial equivalence" to a predicate device. This means showing that the new device has the same intended use, similar technological characteristics, and raises no new questions of safety and effectiveness as a device already on the market.
- "Study" Equivalence: The "study" mentioned in the document refers to mechanical testing to demonstrate substantial equivalence, not a clinical study involving human patients or ground truth derived from expert consensus. Key phrases supporting this are: "Mechanical testing demonstrates substantial equivalence of the new components to the predicate devices in regards to mechanical strength."
Therefore, I cannot populate the requested table or answer the specific questions about acceptance criteria, sample size, ground truth, experts, or MRMC studies because this information is not applicable to the type of device and regulatory submission presented in the input.
The document does provide:
- Intended Use and Indications for Use: These describe the clinical conditions for which the device is designed.
- Substantial Equivalence Statement: This is the core argument of a 510(k), stating the device is similar to existing ones based on intended use, materials, and design, supported by mechanical testing.
{0}------------------------------------------------
Line Extension to the V40" /C-Taper Adaptor Sleeve
JUL 19 2005
K051737 p1/2
Special 510(k) Premarket Notification
510(k) Summary of Safety and Effectiveness Line Extension to the V-40™/C-Taper Adapter Sleeve
| Proprietary Name: | V-40™/C-Taper Adapter Sleeve |
|---|---|
| Common Name: | V40™/C-Taper Adapter Sleeve |
| Proposed Regulatory Class: | Class II |
| Classification: | Hip joint metal/ceramic/polymer semi-constrained cemented ornonporous uncemented prosthesis, 21 CFR §888.3353. |
| Device Product Code: | 87 LZO: Prosthesis, Hip, Semi-Constrained,Metal/Ceramic/Polymer, Cemented or Non-Porous, Uncemented |
| For Information contact: | Karen Ariemma, Senior Regulatory Affairs SpecialistHowmedica Osteonics Corp.325 Corporate DriveMahwah, NJ 07430Telephone: (201) 831-5718Fax: (201) 831-6038Email: karen.ariemma@stryker.com |
| Date Summary Prepared: | June 27, 2005 |
Device Description
The subject V-40" /C-Taper Adapter Sleeve is a tapered sleeve component with a female V-40" taper to provide locking with a Howmedica Osteonics femoral stem with a V-40 * taper. In addition, the sleeve has a tapered male exterior surface that provides locking with Howmedica Osteonics C-Taper Alumina Ceramic Heads.
Device Modification
This submission adds the use of a C-Taper Biolox® Delta Ceramic Femoral Head with the V-40"/C-Taper Adapter Sleeve.
Intended Use
The V40 "/C-Taper Adapter Sleeve is intended to allow either a Howmedica Osteonics C-Taper
{1}------------------------------------------------
K051737 p²/₂
Special 510(k) Premarket Notification
Alumina Head or a Howmedica Osteonics C-Taper Biolox® Delta Ceramic Femoral Head to mate with a Howmedica Osteonics femoral stem with a V40" taper. The V40" /C-Taper Adapter Sleeve is a single-use device.
Indications for Use
For Use as a Total Hip Replacement:
- Painful disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid . arthritis, post-traumatic arthritis or late stage vascular necrosis.
- Revision of previous cup arthroplasty or other procedures. .
- Clinical management problems where arthrodesis or alternative reconstructive techniques are . less likely to achieve satisfactory results.
For Use as a Bipolar Hip Replacement
- Femoral head/neck fractures or non-unions. .
- . Aseptic necrosis of the femoral head.
- Osteo- rheumatoid, and post traumatic arthritis of the hip with minimal acetabular . involvement or distortion.
Other Considerations:
- Pathological considerations or age considerations which indicate a more conservative . acetabular procedure and an avoidance of the use of bone cement in the acetabulum.
- Salvage of failed total hip arthroplasty. .
Substantial Equivalence
The features of the new components are substantially equivalent to the predicate devices based on similarities in intended use, materials and design. Mechanical testing demonstrates substantial equivalence of the new components to the predicate devices in regards to mechanical strength. In addition, the intended use, manufacturing methods, packaging, and sterilization of the predicate and new components are identical. The material of the subject V40"/C-Taper Adapter Sleeve remains unchanged. The subject ceramic femoral heads are fabricated from Zirconia toughened Alumina.
{2}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA
JUL 1 9 2005
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Ms. Karen Ariemma Senior Regulatory Affairs Specialist Howmedica Osteonics Corp. 325 Corporate Drive Mahwah, New Jersey 07432
$\frac{1}{2}$
Re: K051737 Trade/Device Name: V40™/C-Taper Sleeve Regulation Number: 21 CFR 888.3353 Regulation Name: Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis Regulatory Class: II Product Code: LZO Dated: June 27, 2005 Received: June 28, 2005
Dear Ms. Ariemma:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{3}------------------------------------------------
Page 2 - Ms. Karen Ariemma
This letter will allow you to begin marketing your device as described in your Section 510(k) I mis loter will and in yours of substantial equivalence of your device to a legally premaired predicated on "The station for your device and thus, permits your device to proceed to the market. . . . .
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please if you desire specific arrant at (240) 276-0120. Also, please note the regulation entitled, Connact the Office of County of County of Cation" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small other general miormation on Jour Corsumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
E. A. Th
Miriam C. Provost, Ph.D Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Indications for Use
510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________
Device Name: V40"/C-Taper Adapter Sleeve
Indications For Use:
The indications for use of the subject device, in keeping with those of other legally marketed Howmedica Osteonics' adapter sleeves is as follows:
・。
For Use as a Total Hip Replacement
-
Painful disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid . arthritis, post-traumatic arthritis or late stage vascular necrosis.
-
Revision of previous cup arthroplasty or other procedures. .
-
Clinical management problems where arthrodesis or alternative reconstructive techniques are . less likely to achieve satisfactory results.
For Use as a Bipolar Hip Replacement
- Femoral head/neck fractures or non-unions. .
- Aseptic necrosis of the femoral head. .
- Osteo-, rheumatoid, and post traumatic arthritis of the hip with minimal acetabular . involvement or distortion.
Other Considerations:
- Pathological considerations or age considerations which indicate a more conservative . acetabular procedure and an avoidance of the use of bone cement in the acetabulum.
- Salvage of failed total hip arthroplasty. .
Prescription Use _____________________________________________________________________________________________________________________________________________________________
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________
(Part 21 CFR 801 Subpart D)
(21 CFR 807 Subpart C)
ﻨﺘﺸﺘﻬﺎ ﺗﺘﺮﺑ ﺍﻟﺘﻘ
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Page 1 of 1 | |
|---|---|
Division Sign-Off
Division of General Restorative
K051737
§ 888.3353 Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis.
(a)
Identification. A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.(b)
Classification. Class II.